Gene therapy biotech AveXis files for a $115 million IPO - (NASDAQ via NewsPoints Desk)

  • AveXis filed with the US Securities and Exchange Commission to raise up to $115 million in an initial public offering, as reported in NASDAQ.
  • The company, which is developing gene therapies for rare neurological diseases, plans to list on the Nasdaq under the symbol AVXS.

To read more NewsPoints articles, click here.